Promedior's Series B Round

Promedior raised a round of funding on February 19, 2009.

Promedior is a clinical stage immunotherapy company pioneering the development of targeted therapeutics to treat diseases involving fibrosis. Fibrosis occurs when healthy tissue is replaced with exces…

Articles about Promedior's Series B Round: